RT Journal Article
SR Electronic
T1 COVID-19 Confirmed Case Incidence Age Shift to Young Persons Age 0-19 and 20-39 Years Over Time: Washington State March - April 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.21.20109389
DO 10.1101/2020.05.21.20109389
A1 Malmgren, Judith
A1 Guo, Boya
A1 Kaplan, Henry G.
YR 2020
UL http://medrxiv.org/content/early/2020/05/23/2020.05.21.20109389.abstract
AB Background As the coronavirus (COVID-19) epidemic passes the peak infection rate in some states and counties a phased re-opening with changes of stay-at-home restrictions and social distancing recommendations may lead to an increase of non-essential work, social activities and gathering, especially among younger persons.Methods A longitudinal cohort analysis of Washington State Department of Health COVID-19 confirmed case age distribution March 1-April 19 2020 for proportional change over time using chi square tests for significance (N = 13,934).Results From March 1st to April 19, 2020 age distribution shifted with a 10% decline in cases age 60 years and older and a 20% increase in age 0-19/20-39 years (chi-square = 223.10, p <.001). Number of cases over the eight-week analysis period were 0-19 years n = 515, 20-39 years n = 4078, 40-59 years n =4788, 60-79 years n = 3221, 80+ years n = 1332. New cases increased steadily among 0-19 and 20-39-year olds. After the peak (March 22, 2020), there was no decline among age 0-19 and a lesser decline among age 20-39 than older groups. As incidence declined in older age groups, the combined percentage of cases age 0-19 and 20-39 increased from 20% to 40% of total cases.Conclusions Increased COVID-19 infection among children and young adults is not without serious morbidity and mortality risk to them and others they may come in contact with, indicating a targeted approach for awareness and safety measures is advisable to reduce incidence among the supposedly less vulnerable but more mobile young population age 0-19 and 20-39 years.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding of any sort was provided by any entity for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:none needed. Publicly available deidentified data was downloaded from the Washington State Department of Health COVID-19 Dashboard tab #2 for confirmed cases and hospitalizationsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used was publicly available deidentified data downloaded from the Washington State Department of Health COVID-19 Dashboard tab #2 for confirmed cases and hospitalizations https://www.doh.wa.gov/Emergencies/NovelCoronavirusOutbreak2020COVID19/DataDashboard https://www.doh.wa.gov/Emergencies/NovelCoronavirusOutbreak2020COVID19/DataDashboard